Cyproterone acetate-ethinyl estradiol use in a 23-year-old woman with stroke.
作者信息
Kromm Julie, Jeerakathil Thomas
机构信息
Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Alta.
出版信息
CMAJ. 2014 Jun 10;186(9):690-3. doi: 10.1503/cmaj.130579. Epub 2014 Feb 3.
Abstract
摘要
相似文献
1
Cyproterone acetate-ethinyl estradiol use in a 23-year-old woman with stroke.
CMAJ. 2014 Jun 10;186(9):690-3. doi: 10.1503/cmaj.130579. Epub 2014 Feb 3.
2
[Oral contraceptives, risks and hazards].
Ann Dermatol Venereol. 2014 Jan;141(1):5-6. doi: 10.1016/j.annder.2013.12.001. Epub 2014 Jan 10.
3
Too much disclosure of product risks? CBC television, SOGC, and Diane-35.
J Obstet Gynaecol Can. 2003 Apr;25(4):268-9; discussion 270-3. doi: 10.1016/s1701-2163(16)31028-3.
4
Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.
Hum Reprod. 2008 Feb;23(2):231-2. doi: 10.1093/humrep/dem379. Epub 2007 Dec 14.
5
[A cyproterone acetate-ethinyl estradiol combination in the treatment of acne. Data of a survey of gynecologists].
Minerva Ginecol. 1988 Feb;40(2):125-32.
6
[Cyproterone acetate].
Hautarzt. 2002 Feb;53(2):149. doi: 10.1007/s001050200000.
7
[The hypocrisy of Diane®].
Ann Dermatol Venereol. 2013 Apr;140(4):249-50. doi: 10.1016/j.annder.2013.02.004. Epub 2013 Mar 7.
8
Cyclic cyproterone/ethinyloestradiol in acne.
Lancet. 1983 Oct 15;2(8355):910-1. doi: 10.1016/s0140-6736(83)90892-9.
9
Cyclic cyproterone/ethinyloestradiol for acne.
Lancet. 1983 Aug 20;2(8347):458.
10
Cervical spinal cord infarction associated with the use of oral contraceptives for the treatment of acne in a healthy young woman.
J Postgrad Med. 2015 Jan-Mar;61(1):36-7. doi: 10.4103/0022-3859.147036.
引用本文的文献
1
"The Great Masquerader": An Interesting Case Series of Pulmonary Thromboembolism.
Cureus. 2022 Dec 8;14(12):e32330. doi: 10.7759/cureus.32330. eCollection 2022 Dec.
2
Research Trends of Acupuncture Therapy on Polycystic Ovary Syndrome: A Bibliometric Analysis.
Evid Based Complement Alternat Med. 2022 Oct 12;2022:1989401. doi: 10.1155/2022/1989401. eCollection 2022.
3
Use of oral contraceptives for management of acne vulgaris and hirsutism in women of reproductive and late reproductive age.
Prz Menopauzalny. 2018 Mar;17(1):1-4. doi: 10.5114/pm.2018.74895. Epub 2018 Apr 11.
本文引用的文献
1
Thrombotic stroke and myocardial infarction with hormonal contraception.
N Engl J Med. 2012 Jun 14;366(24):2257-66. doi: 10.1056/NEJMoa1111840.
2
Hormonal contraception and venous thromboembolism.
Acta Obstet Gynecol Scand. 2012 Jul;91(7):769-78. doi: 10.1111/j.1600-0412.2012.01444.x.
3
Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9.
BMJ. 2011 Oct 25;343:d6423. doi: 10.1136/bmj.d6423.
4
Risk factors for heart attack, stroke, and venous thrombosis associated with hormonal contraceptive use.
Clin Appl Thromb Hemost. 2011 Aug;17(4):323-31. doi: 10.1177/1076029610368670. Epub 2010 Jun 7.
5
Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.
Hum Reprod. 2008 Feb;23(2):231-2. doi: 10.1093/humrep/dem379. Epub 2007 Dec 14.
6
Medicine by media: did a critical television documentary affect the prescribing of cyproterone--estradiol (Diane-35)?
CMAJ. 2005 Nov 22;173(11):1313-5. doi: 10.1503/cmaj.050567.
7
Diane-35 (cyproterone acetate): safety concerns.
CMAJ. 2003 Feb 18;168(4):455-6.
8
SOGC clinical practice guidelines. Hirsutism: evaluation and treatment.
J Obstet Gynaecol Can. 2002 Jan;24(1):62-73, 77-9.
9
Treatment of acne vulgaris and prevention of acne scarring: canadian consensus guidelines.
J Cutan Med Surg. 2000 Jun;4 Suppl 1:S2-13.
10
Hepatocellular carcinoma after treatment with cyproterone acetate combined with ethinyloestradiol.
Lancet. 1995 Feb 18;345(8947):452-3. doi: 10.1016/s0140-6736(95)90434-4.
Zotero 插件